SEC Form 4 · accession 0001387131-16-004331

Ohr Pharmaceutical Inc · OHRP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Feb 22, 2016

Accepted (ET)

Feb 23, 2016 · 1:25 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001173281

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock, par value $0.0001 per share	Feb 22, 2016	P	100	$3.21	A	865,854	D
Common Stock, par value $0.0001 per share	Feb 22, 2016	P	300	$3.15	A	866,154	D
Common Stock, par value $0.0001 per share	Feb 22, 2016	P	100	$3.14	A	866,254	D
Common Stock, par value $0.0001 per share	Feb 22, 2016	P	200	$3.13	A	866,454	D
Common Stock, par value $0.0001 per share	Feb 22, 2016	P	700	$3.12	A	867,154	D
Common Stock, par value $0.0001 per share	Feb 22, 2016	P	3,550	$3.11	A	870,704	D
Common Stock, par value $0.0001 per share	Feb 22, 2016	P	100	$3.10	A	870,804	D
Common Stock, par value $0.0001 per share	Feb 22, 2016	P	200	$3.09	A	871,004	D
Common Stock, par value $0.0001 per share	Feb 22, 2016	P	500	$3.08	A	871,504	D
Common Stock, par value $0.0001 per share	Feb 22, 2016	P	300	$3.07	A	871,804	D
Common Stock, par value $0.0001 per share	Feb 22, 2016	P	200	$3.06	A	872,004	D
Common Stock, par value $0.0001 per share^F1	holding	—	—		—	697,865	I	BY SKS Ocular I LLC

No Table II lines on this filing.

F1SKS Ocular I LLC directly owns the shares of Common Stock. On May 30, 2014, the Issuer completed an ophthalmology assets acquisition of SKS Ocular LLC and SKS Ocular I LLC. Pursuant to the acquisition agreement, among other things, SKS Ocular I LLC is eligible to receive additional shares of Common Stock in three contingent milestone payments. Milestone 1 has been met and on December 15, 2015, the Issuer issued 497,859 shares of Common Stock to SKS Ocular I LLC. The Reporting Person has investment and voting power with respect to the Common Stock held by SKS Ocular 1 LLC. Therefore, the Reporting Person may be deemed to beneficially own the shares of Common Stock beneficially owned by SKS Ocular 1 LLC. The Reporting Person disclaims any beneficial ownership of the Common Stock directly owed by SKS Ocular I LLC except to the extent of his pecuniary interest therein.